Sujin Cho-Schultz

Discovery of <i>N</i>-((3<i>R</i>,4<i>R</i>)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1<i>H</i>-pyrazol-4-yl)amino)-9-methyl-9<i>H</i>-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR

Simon Planken, Douglas C. Behenna, Sajiv K. Nair et al. · Journal of Medicinal Chemistry · 2017 · 89 citations · Full text

Molecular Biology, Wild-type Egfr, Chemical Biology +21

CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety

Cynthia L. Palmer, Britton Boras, Bernadette Pascual et al. · Cancer Cell · 2025 · 35 citations · Full text

Design and Synthesis of Functionally Active 5-Amino-6-Aryl Pyrrolopyrimidine Inhibitors of Hematopoietic Progenitor Kinase 1

Rebecca A. Gallego, Louise Bernier, Hui Chen et al. · Journal of Medicinal Chemistry · 2023 · 33 citations · Full text

Discovery of PF-07265028, A Selective Small Molecule Inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) for the Treatment of Cancer

Rebecca A. Gallego, Sujin Cho-Schultz, Matthew Del Bel et al. · Journal of Medicinal Chemistry · 2024 · 16 citations

Solution-Phase Parallel Synthesis of Hsp90 Inhibitors

Sujin Cho-Schultz, Monica Jo Patten, Buwen Huang et al. · Journal of Combinatorial Chemistry · 2009 · 15 citations

Medicinal Chemistry, Biochemistry, Hsp90 Inhibitors +12